MX340559B - Proteinas de tcr de alta afinidad y metodos. - Google Patents
Proteinas de tcr de alta afinidad y metodos.Info
- Publication number
- MX340559B MX340559B MX2012000116A MX2012000116A MX340559B MX 340559 B MX340559 B MX 340559B MX 2012000116 A MX2012000116 A MX 2012000116A MX 2012000116 A MX2012000116 A MX 2012000116A MX 340559 B MX340559 B MX 340559B
- Authority
- MX
- Mexico
- Prior art keywords
- cell receptor
- coding sequence
- tcrs
- high affinity
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Pathology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
Abstract
La presente invención se refiere a un método in vitro para clonar el gen para un mutante de TCR de alta afinidad en un sistema que permite la expresión del mutante sobre la superficie de células T, caracterizado porque comprende las etapas de: mutar las TCR para crear mutantes de TCR de alta afinidad los cuales tienen una afinidad por su ligando relacionado de entre 107 M-1 y 1010 M-1, en donde los mutantes de TCR de alta afinidad portan una o más mutaciones en una CDR, y en donde las mutaciones son una o más de los residuos 93 a 104 de CDR3? o uno o más de los residuos 95 a 107 de CDR3ß; clonar los mutantes de TCR en un vector; transfectar el vector en células T; y expresar el mutante de TCR de alta afinidad sobre la superficie de células t, en donde el ligando es un ligando péptido/MHC. El método de las células transfectadas se usan para reconocimiento de células MHC que presentan el péptido seleccionado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16917999P | 1999-12-06 | 1999-12-06 | |
PCT/US2000/042622 WO2001048145A2 (en) | 1999-12-06 | 2000-12-06 | High affinity tcr proteins and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MX340559B true MX340559B (es) | 2016-07-14 |
Family
ID=22614526
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02005559A MXPA02005559A (es) | 1999-12-06 | 2000-12-06 | Proteinas de tcr de alta afinidad y metodos. |
MX2012000116A MX340559B (es) | 1999-12-06 | 2000-12-06 | Proteinas de tcr de alta afinidad y metodos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02005559A MXPA02005559A (es) | 1999-12-06 | 2000-12-06 | Proteinas de tcr de alta afinidad y metodos. |
Country Status (9)
Country | Link |
---|---|
EP (4) | EP2042869B1 (es) |
JP (4) | JP4972264B2 (es) |
AT (1) | ATE411522T1 (es) |
AU (1) | AU5076301A (es) |
CA (1) | CA2406668C (es) |
DE (1) | DE60040556D1 (es) |
DK (1) | DK1247095T3 (es) |
MX (2) | MXPA02005559A (es) |
WO (1) | WO2001048145A2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
US20020165149A1 (en) * | 2000-12-08 | 2002-11-07 | Kranz David M. | Mutated class II major histocompatibility proteins |
EP2075256A2 (en) | 2002-01-14 | 2009-07-01 | William Herman | Multispecific binding molecules |
AU2003304374A1 (en) * | 2002-08-29 | 2005-02-14 | Baylor College Of Medicine | Peptide inhibitors of beta-lactamases |
WO2005046449A2 (en) | 2003-11-10 | 2005-05-26 | Altor Bioscience Corporation | Soluble tcr molecules and methods of use |
PL1772465T3 (pl) | 2005-01-05 | 2009-08-31 | F Star Biotechnologische Forschungs Und Entw M B H | Syntetyczne domeny immunoglobulinowe o właściwościach wiążących modyfikowane w regionach cząsteczki różnych od regionów determinujących komplementarność |
US7534762B2 (en) | 2005-03-18 | 2009-05-19 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
AU2006224944B2 (en) * | 2005-03-18 | 2012-01-12 | Novozymes Adenium Biotech A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
AT503861B1 (de) * | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von t-zell-rezeptoren |
AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
CN101802006B (zh) | 2007-06-26 | 2013-08-14 | F-星生物技术研究与开发有限公司 | 展示结合剂 |
EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
RU2742607C1 (ru) | 2013-03-28 | 2021-02-09 | Медикаго Инк. | Получение вирусоподобных частиц вируса гриппа в растениях |
ES2864081T3 (es) | 2014-01-10 | 2021-10-13 | Medicago Inc | Elementos potenciadores de CPMV |
EP3590958A1 (en) | 2014-03-14 | 2020-01-08 | Immunocore Limited | Tcr libraries |
CA2943796C (en) | 2014-03-27 | 2023-02-14 | Medicago Inc. | Modified cpmv enhancer elements |
GB201516265D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
GB201516275D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
GB201516277D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR libraries |
GB201516272D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
GB201516269D0 (en) | 2015-09-15 | 2015-10-28 | Adaptimmune Ltd And Immunocore Ltd | TCR Libraries |
GB201604953D0 (en) | 2016-03-23 | 2016-05-04 | Immunocore Ltd | T cell receptors |
CR20180531A (es) | 2016-04-08 | 2019-06-13 | Immunocore Ltd | Receptores de células t |
GB201709866D0 (en) | 2017-06-20 | 2017-08-02 | Immunocore Ltd | T cell receptors |
CN109777778B (zh) * | 2017-11-14 | 2023-07-18 | 中国科学院广州生物医药与健康研究院 | 一种基因改造的γδT细胞 |
WO2019151392A1 (ja) * | 2018-01-31 | 2019-08-08 | 国立大学法人東北大学 | 抗原特異的mhc発現調節法 |
US20220275043A1 (en) | 2018-07-17 | 2022-09-01 | Massachusetts Institute Of Technology | Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof |
GB201904328D0 (en) | 2019-03-28 | 2019-05-15 | Immunocore Ltd | Specific binding molecules |
US20210032370A1 (en) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Recruiting agent further binding an mhc molecule |
DE102019121007A1 (de) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigenbindende Proteine, die spezifisch an MAGE-A binden |
US20210048442A1 (en) * | 2019-08-13 | 2021-02-18 | Immatics Biotechnologies Gmbh | Method for the characterization of peptide:mhc binding polypeptides |
GB201915282D0 (en) | 2019-10-22 | 2019-12-04 | Immunocore Ltd | Specific binding molecules |
WO2021144020A1 (en) | 2020-01-15 | 2021-07-22 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
GB202006629D0 (en) | 2020-05-05 | 2020-06-17 | Immunocore Ltd | Specific binding molecules |
GB202010329D0 (en) | 2020-07-06 | 2020-08-19 | Immunocore Ltd | Specific binding molecules |
WO2022184805A1 (en) | 2021-03-03 | 2022-09-09 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein |
MX2023012902A (es) | 2021-05-05 | 2023-11-08 | Immatics Biotechnologies Gmbh | Proteinas de union a antigenos que se unen especificamente a prame. |
WO2023156663A1 (en) | 2022-02-20 | 2023-08-24 | Immunocore Limited | Hiv-specific binding molecules and tcr |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3927193A (en) | 1973-05-18 | 1975-12-16 | Hoffmann La Roche | Localization of tumors by radiolabelled antibodies |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4444744A (en) | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
US4348376A (en) | 1980-03-03 | 1982-09-07 | Goldenberg Milton David | Tumor localization and therapy with labeled anti-CEA antibody |
US4361544A (en) | 1980-03-03 | 1982-11-30 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers |
US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4468457A (en) | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
US5101827A (en) | 1985-07-05 | 1992-04-07 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
US4640561A (en) | 1985-11-15 | 1987-02-03 | Ford Motor Company | Flexible printed circuit connector |
US5059413A (en) | 1988-04-18 | 1991-10-22 | Xoma Corporation | Scintigraphic monitoring of immunotoxins using radionuclides and heterobifunctional chelators |
EP0486622B1 (en) | 1989-08-09 | 1998-11-04 | Rhomed, Incorporated | Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
US5299253A (en) | 1992-04-10 | 1994-03-29 | Akzo N.V. | Alignment system to overlay abdominal computer aided tomography and magnetic resonance anatomy with single photon emission tomography |
US5861156A (en) * | 1993-01-08 | 1999-01-19 | Creative Biomolecules | Methods of delivering agents to target cells |
US6300065B1 (en) * | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
AU6685698A (en) * | 1997-03-07 | 1998-09-22 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
-
2000
- 2000-12-06 WO PCT/US2000/042622 patent/WO2001048145A2/en active Application Filing
- 2000-12-06 MX MXPA02005559A patent/MXPA02005559A/es active IP Right Grant
- 2000-12-06 DE DE60040556T patent/DE60040556D1/de not_active Expired - Lifetime
- 2000-12-06 CA CA2406668A patent/CA2406668C/en not_active Expired - Lifetime
- 2000-12-06 EP EP08075788.3A patent/EP2042869B1/en not_active Expired - Lifetime
- 2000-12-06 MX MX2012000116A patent/MX340559B/es unknown
- 2000-12-06 JP JP2001548658A patent/JP4972264B2/ja not_active Expired - Lifetime
- 2000-12-06 EP EP10184889A patent/EP2287185A3/en not_active Withdrawn
- 2000-12-06 EP EP10183227A patent/EP2336775A3/en not_active Withdrawn
- 2000-12-06 AU AU50763/01A patent/AU5076301A/en not_active Abandoned
- 2000-12-06 DK DK00993099T patent/DK1247095T3/da active
- 2000-12-06 EP EP00993099A patent/EP1247095B1/en not_active Expired - Lifetime
- 2000-12-06 AT AT00993099T patent/ATE411522T1/de not_active IP Right Cessation
-
2010
- 2010-12-17 JP JP2010282453A patent/JP2011101649A/ja not_active Withdrawn
-
2011
- 2011-12-29 JP JP2011290233A patent/JP2012065672A/ja active Pending
-
2014
- 2014-01-17 JP JP2014006599A patent/JP2014095722A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MXPA02005559A (es) | 2004-09-10 |
EP2287185A2 (en) | 2011-02-23 |
WO2001048145A2 (en) | 2001-07-05 |
JP4972264B2 (ja) | 2012-07-11 |
EP2336775A3 (en) | 2013-03-20 |
EP2287185A3 (en) | 2012-10-10 |
EP2336775A2 (en) | 2011-06-22 |
ATE411522T1 (de) | 2008-10-15 |
WO2001048145A3 (en) | 2002-01-10 |
CA2406668C (en) | 2015-11-24 |
JP2014095722A (ja) | 2014-05-22 |
EP1247095A4 (en) | 2003-04-02 |
DK1247095T3 (da) | 2008-12-08 |
JP2011101649A (ja) | 2011-05-26 |
EP2042869A3 (en) | 2009-06-17 |
DE60040556D1 (de) | 2008-11-27 |
EP1247095A2 (en) | 2002-10-09 |
AU5076301A (en) | 2001-07-09 |
CA2406668A1 (en) | 2001-07-05 |
EP1247095B1 (en) | 2008-10-15 |
JP2003518377A (ja) | 2003-06-10 |
EP2042869B1 (en) | 2017-10-04 |
EP2042869A2 (en) | 2009-04-01 |
JP2012065672A (ja) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02005559A (es) | Proteinas de tcr de alta afinidad y metodos. | |
EP2360265A3 (en) | Yeast cell surface display of proteins and uses thereof | |
AU6597998A (en) | HLA-A2.1 binding peptides and their uses | |
CY2586B2 (en) | Modulators of the function of FAS/APO1 receptors | |
EP1526141A3 (en) | MHC complexes and uses thereof | |
DK0669929T3 (da) | Elk-ligand, et cytokin | |
HK1006854A1 (en) | Nucleic acid encoding a t-cell antigen receptor polypeptide | |
EP1137808A4 (en) | METHODS OF MAKING RECOMBINANT CELLS | |
MX9802730A (es) | Agonistas receptores hematopoyeticos multifuncionales. | |
GR3022080T3 (en) | T-cell receptor gene located within alpha locus and dna constructions | |
AU1093597A (en) | Vector for expression of n-terminally extended proteins in yeast cell | |
EP1734053A3 (en) | Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations | |
EP0892046A3 (en) | Melatonin-receptor expression cells and their uses | |
WO1996040939A3 (en) | Expression of functional vertebrate phospholipases in yeast | |
Halstensen et al. | In situ two-and three-color immunofluorescence staining of mucosal T-cells in celiac disease. Increase of TCR gamma/delta+ CD8-and TCR alpha/beta+ CD45R0+ intraepithelial lymphocytes and IL-2R+ TCR alpha/beta+ CD4+ CD45R0+ lamina propria lymphocytes | |
WO1998054223A3 (en) | Immunological method | |
DK0706567T3 (da) | Peptidfamilie betegnet xenoxiner | |
AU4365196A (en) | Purified genes encoding mammalian cell surface antigens; proteins and antibodies | |
Vogel et al. | Informational Macromolecules | |
Morrison | Bioseparations-Flight experiment support research | |
Muntasell et al. | A large number of peptides of cytosolic origin associate to HLA-DR molecules in epithelial cells, showing a different pattern from conventional antigen presenting cells | |
Hurtley | Modeling fine-tuned affinity | |
Sparre et al. | Similarities in expression levels of proteins in IL-1β stimulated BB-DP islets and islets syngrafted to BB-DP rats | |
MX9700213A (es) | Citocina novedosa designada como lerk-5. | |
RU93004705A (ru) | Олигосахариды, фармацевтическая композиция, применение олигосахаридов |